Wed.Mar 19, 2025

article thumbnail

Evvy Launches Fertility Insights Offering Via Vaginal Microbiome Test

MedCity News

Through Evvy’s vaginal microbiome test, consumers can now receive insights on fertility. The vaginal microbiome is often overlooked when it comes to fertility, according to Priyanka Jain, CEO and co-founder of Evvy. The post Evvy Launches Fertility Insights Offering Via Vaginal Microbiome Test appeared first on MedCity News.

159
159
article thumbnail

Which Social Media Analytics Matter Most in Pharma Marketing

Pharma Marketing Network

Introduction Social media has become an essential tool for pharmaceutical marketing. However, simply posting content is not enough. To measure success and improve engagement, pharma marketing teams must focus on the right social media analytics. But which metrics truly matter? With increasing regulations, evolving digital trends, and shifting audience behaviors, pharma marketers need to analyze data that aligns with brand goals, compliance requirements, and engagement strategies.

Media 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The key factors shaping China’s biopharma boom

PharmaVoice

Chinese companies are involved in one-fifth of pharma’s clinical development programs, but trade wars and regulatory hurdles could stymie dealmaking.

Biopharma 147
article thumbnail

Audience Engagement Strategies for Pharma Marketing: Boost HCP and Patient Interaction

Pharma Marketing Network

Introduction In the highly regulated pharmaceutical industry, audience engagement is more than just a marketing goalit is a necessity for building trust with healthcare professionals (HCPs) and patients. But how can pharma brands create meaningful connections in a digital landscape crowded with content? Unlike traditional consumer marketing, pharma marketing requires a strategic approach that balances compliance, education, and innovation.

article thumbnail

The Intersection of AI and Sales: Personalization Without Compromise

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

article thumbnail

Sarepta slumps on Elevidys patient death

pharmaphorum

The death of a patient treated with Sarepta's Duchenne muscular dystrophy gene therapy Elevidys has hit its share price

More Trending

article thumbnail

Google promises new AI models for drug discovery

pharmaphorum

Google has said it will release new open-source AI models for drug discovery, TxGemma, through a developers' programme later this month

71
article thumbnail

Sacklers to pay up to $7bn in Purdue Pharma’s opioid settlement plan

Pharmaceutical Technology

Purdue Pharmas new bankruptcy plan outlines the payment structure of the largest opioid settlement to date.

Pharma 69
article thumbnail

Novartis sheds staff as Entresto patent expiry looms

pharmaphorum

Novartis will cut 427 jobs this year in the US as it prepares for the loss of market exclusivity for its blockbuster heart failure therapy Entresto

article thumbnail

Allogeneic cell therapies “poised for prime time” says expert

Pharmaceutical Technology

While the allogeneic vs autologous debate continues in the cell therapy field, research on in vivo therapies is drawing interest.

59
article thumbnail

5 Ways You Can Win Faster with Gen AI in Sales

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

article thumbnail

Roche taps Oxford BioTherapeutics for cancer drug discovery

pharmaphorum

Oxford BioTherapeutics has lined up another big pharma partner for its drug discovery platform, signing a $1bn deal with oncology giant Roche

Pharma 59
article thumbnail

USPTO allows patents for Remedy’s large hemispheric infarction drug

Pharmaceutical Technology

The US Patent and Trademark Office (USPTO) has allowed two new patents for Remedy Pharmaceuticals Cirara, aimed at treating LHI.

article thumbnail

Access USA 2025: Spreading Awareness of Medicare Part D Reforms

Pharmaceutical Commerce

The conferences first panel offers insight on the current state of awareness among beneficiaries of the Part D cap and Medicare Prescription Payment Plan via the PAN Foundations latest research.

article thumbnail

Arbor to advance gene editing treatments with $73.9m funding

Pharmaceutical Technology

Arbor Biotechnologies has closed $73.9m for its gene editing therapeutic pipeline aimed at liver and central nervous system diseases.

59
article thumbnail

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

article thumbnail

PAP 2025: How Charitable Programs Are Evolving to Improve Patient Access to Life-Saving Medications

Pharmaceutical Commerce

Jonathan James, CEO, Hope Charities, discusses reimbursement challenges and barriers to care in patients requiring life-saving medications.

Medical 52
article thumbnail

Insight and insitro partner on AI model to seek ocular biomarkers

Pharmaceutical Technology

Insight Health Data Research Hub and insitro have announced a partnership to develop an AI foundation model for ocular biomarkers.

59
article thumbnail

DCAT Week 2025: Key Ingredients in Pharmaceutical Manufacturing

PharmaTech

Roquette Pharma Solutions' Christine Mya-San, global account manager, highlights the most significant pharma ingredients at play over the past year and discusses future ingredient innovation.

article thumbnail

Access USA 2025: Uncovering Patient Access Complexities

Pharmaceutical Commerce

A roundtable explores how patient access needs are being measured, while also discussing the value of affordability in decision-making.

article thumbnail

10 Ways to Leverage Buyer Signals and Drive Revenue

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

article thumbnail

SGD Pharma Details Latest Sustainability Investments at DCAT Week 2025

PharmaTech

The company is highlighting its commitment to next-generation glass manufacturing in efforts to strengthen the pharmaceutical supply chain.

Pharma 52
article thumbnail

Funding Roundup: Recent Financing Rounds Completed for Pain, Cancer, and Musculoskeletal Care Innovations

PharmExec

Latigo Biotherapeutics, Vivace Therapeutics, and Vori Health each announced the recent successful closing of their respective financing rounds.

52
article thumbnail

AI Aftershocks: US Copyright Licensing Booms

Copyright Clearance Center

Copyright lawsuits against AI developers could take decades. In the meantime, the media are racing to license content to AI companies.

Media 52
article thumbnail

Phase III Trials Show Povorcitinib Significantly Improves Hidradenitis Suppurativa Outcomes

PharmExec

In the Phase III STOP-HS1 and STOP-HS2 trials, results show that patients treated with povorcitinib for hidradenitis suppurativa experienced a 50% reduction in the total abscess and inflammatory nodule count.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

CCC Readies an AI Systems Training License

Copyright Clearance Center

CCC is introducing an AI Systems Training Licenselater in 2025 for both existing and prospective CCC customers. This voluntary, non-exclusive license will help organizations use copyrighted works lawfully when training AI systems with third-party content.

article thumbnail

DCAT Week 2025: Industry Need for Continuous Biologics Manufacturing

PharmaTech

Russell Miller, vice-president of Global Sales & Marketing at Enzene, explains that continuous bioprocessing is poised to change biologics manufacturing moving forward.

article thumbnail

Access USA 2025: How Charitable Programs Are Evolving to Improve Patient Access to Life-Saving Medications

Pharmaceutical Commerce

Jonathan James, CEO, Hope Charities, discusses reimbursement challenges and barriers to care in patients requiring life-saving medications.

Medical 52
article thumbnail

DCAT Week 2025: Enzymatic RNA Synthesis

PharmaTech

PharmTech Group spoke with Alison Moore, chief technical officer, Codexis to find out the latest about the RNA therapy market and to get perspective on how enzymatic RNA synthesis is used to synthesize RNA molecules.

article thumbnail

Signal-Based Selling: How to Leverage 4 Key Buying Signals

As prospects define their problem, search for solutions, and even change jobs, they are generating high-value signals that the best go-to-market teams can leverage to close more deals. This is where signal-based selling comes into play. ZoomInfo CEO Henry Schuck recently broke down specific ways to put four key buying signals into action with the experts from 30 Minutes to President’s Club.

article thumbnail

Pharma Pulse 3/19/25: Strategies to Close Women’s Health Innovation Gap, Enhancing Patient Care in Heart Failure–Related Anemia & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Pharma 52
article thumbnail

DCAT Week 2025: Keeping Up with Drug Demand

PharmaTech

PharmTech Group sat down with Anil Kane of Thermo Fisher Scientific live on site at DCAT Week 2025, to talk about technologies and digital solutions companies are using to meet demand across the bio/pharma industry.

Pharma 52
article thumbnail

Strategizing for an Uncertain Trade War: Q&A with Anshul Mangal

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52